Hiroki Ikezawa
Hiroki Ikezawa publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as HER2/EGFR in Cancer Research, Cholangiocarcinoma and Gallbladder Cancer Studies and Fibroblast Growth Factor Research.
- World rank
- #2,682,323 of 7,710,434 ranked researchers
- Rank in Japan
- #56,316 of 383,136
- Works
- 56
- Citations
- 794
- Citations per work
- 14.2
What does Hiroki Ikezawa research?
Hiroki Ikezawa's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3359.3%
- Medicine3359.3%
- Everything else1628.1%
- Life Sciences712.6%
- 1Oncology28% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Surgery10% of their works
- 4Molecular Biology9% of their works
- 5Hepatology5% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Hiroki Ikezawa's research?
The keywords of their largest research topics: Metastatic, Chemotherapy, Prognostic Factors, Therapy, Treatment, Breast Cancer, HER2 and Immunotherapy.
- Chemotherapy-Induced Peripheral Neuropathy
- Pancreatic Cancer
- PD-1 and PD-L1
- Liver Cancer
- Hepatocellular Carcinoma
- FGF21
- Biliary Tract Cancer
- Immunotherapy
- Breast Cancer
- Therapy
- Chemotherapy
- Metastatic
- Prognostic Factors
- Treatment
- HER2
- Tumor Microenvironment
- Cholangiocarcinoma
- Fibroblast Growth Factor
- Immune Checkpoint Blockade
- Molecular Characterization
- Renal Cell Carcinoma
- Surgical Complications
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Metastatic172 topics
- Chemotherapy162 topics
- Prognostic Factors142 topics
- Therapy122 topics
- Treatment122 topics
- Breast Cancer111 topic
- HER2111 topic
- Immunotherapy112 topics
- Tumor Microenvironment112 topics
- Biliary Tract Cancer81 topic
- Cholangiocarcinoma81 topic
- FGF2161 topic
- Fibroblast Growth Factor61 topic
- Hepatocellular Carcinoma61 topic
- Immune Checkpoint Blockade61 topic
- Liver Cancer61 topic
- Molecular Characterization61 topic
- PD-1 and PD-L161 topic
- Renal Cell Carcinoma61 topic
- Pancreatic Cancer51 topic
- Surgical Complications51 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Taxanes41 topic
Where does Hiroki Ikezawa work?
Hiroki Ikezawa's main affiliation in the publication record is Eisai (Japan), Japan.
How many publications and citations does Hiroki Ikezawa have?
OpenAlex counts 56 works and 794 citations for Hiroki Ikezawa, an h-index of 14, ranking #2,682,323 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroki Ikezawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.